Cas:826-39-1 UNII:4956DJR58O manufacturer & supplier

Chemical Name:UNII:4956DJR58O

CAS.NO:826-39-1

Synonyms:bicyclo[2.2.1]heptan-2-amine, N,2,3,3-tetramethyl-, hydrochloride;EINECS 212-555-8;N,2,2,3-tetramethylbicyclo[2.2.1]heptan-3-amine,hydrochloride;N,2,3,3-tétraméthylbicyclo[2.2.1]heptan-2-amine chlorhydrate;2-(Methylamino)-2,3,3-trimethylnorbornane hydrochloride;N,2,3,3-Tetramethylbicyclo[2.2.1]heptan-2-amine hydrochloride;Norbornane, 2-(methylamino)-2,3,3-trimethyl-, hydrochloride;Bicyclo[2.2.1]heptan-2-amine, N,2,3,3-tetramethyl-, hydrochloride (1:1);N,2,3,3-Tetramethylbicyclo[2.2.1]heptan-2-amine hydrochloride (1:1);N,2,3,3-Tetramethylbicyclo[2.2.1]heptan-2-aminhydrochlorid;Inversine hydrochloride;N,2,3,3-tetramethyl-2-norcamphanamine hydrochloride;UNII:4956DJR58O;MFCD00151462

Molecular Formula:C₁₁H₂₂ClN

Molecular Weight:203.752

HS Code:2921300090

Physical and Chemical Properties:

Melting point:>240ºC (dec.)

Boiling point:189.3ºC at 760 mmHg

Density:N/A

Index of Refraction:

PSA:12.03000

Exact Mass:203.144073

LogP:3.61350

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:UN 2811 6

Packing Group:

Contact us for information like bicyclo[2.2.1]heptan-2-amine, N,2,3,3-tetramethyl-, hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00151462 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N,2,3,3-tétraméthylbicyclo[2.2.1]heptan-2-amine chlorhydrate Use and application,MFCD00151462 technical grade,usp/ep/jp grade.

Related News: It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance. UNII:4956DJR58O manufacturer ��CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,�� said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics. UNII:4956DJR58O supplier A new case of coronavirus has been reported in the United Arab Emirates, the country’s fifth, the Ministry of Health and Prevention announced on Saturday. UNII:4956DJR58O vendor The Environmental Working Group, a nonprofit advocacy organization, applauded the bill’s introduction. UNII:4956DJR58O factory ��CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,�� said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics.